NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Myla Goldman
University of Virginia - Charlottesville / United States
Medical and Health Sciences / Neurology
AD Scientific Index ID: 1683434
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Myla Goldman's MOST POPULAR ARTICLES
1-)
Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controlsMD Goldman, RA Marrie, JA CohenMultiple Sclerosis Journal 14 (3), 383-390, 20086112008
2-)
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open …R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ...The Lancet Neurology 17 (5), 405-415, 20182852018
3-)
Multiple sclerosis progression: time for a new mechanism-driven frameworkT Kuhlmann, M Moccia, T Coetzee, JA Cohen, J Correale, J Graves, ...The Lancet Neurology 22 (1), 78-88, 20233322023
4-)
Validity of performance scales for disability assessment in multiple sclerosisRA Marrie, M GoldmanMultiple Sclerosis Journal 13 (9), 1176-1182, 20073272007
5-)
Phase 2 trial of ibudilast in progressive multiple sclerosisRJ Fox, CS Coffey, R Conwit, ME Cudkowicz, T Gleason, A Goodman, ...New England Journal of Medicine 379 (9), 846-855, 20182932018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept